GARY M. COHEN
Gary Cohen is Executive Vice President, Global Health and President of the BD Foundation at BD (Becton, Dickinson and Company), a global medical technology company employing 65,000 people worldwide. He joined BD in 1983 and has served as an officer since 1996. He previously served as Executive Vice President of International Operations from 2008 to 2012, and as Executive Vice President and President of the BD Medical segment from 1998 to 2008. Prior to this, he served as President of Europe, Middle East and Africa and as President of two of the company’s global business units (Sample Collection and Injection Systems).
Mr. Cohen is a board director of UNICEF USA and the Global Partnership to End Violence Against Children, and board co-chair of GBCHealth.
He previously served as board director of the Perrigo Company for 16 years and as board director of the U.S. Centers for Disease Control and Prevention (CDC) Foundation for 13 years, including as board chair. He presently serves as chair of the CDC/Corporate Roundtable on Global Health Threats. He is also founder and board chair of Together for Girls (), a partnership of six UN agencies, the governments of the United States and Canada and the national governments of 23 countries in Africa, Asia, Eastern Europe, Central America and the Caribbean to stop gender-based violence against girls. He previously served as a Commissioner on the UN Commission on Life Saving Commodities for Women and Children.
In his present role at BD, Mr. Cohen leads the company’s collaborative engagement with the public and nonprofit sectors to advance progress on addressing global health needs in areas prioritized by governments and health agencies (). He and the global health team at BD utilize the skills, efficiency and innovation competencies of the business sector to tackle complex and challenging health and social problems, working with international agencies, governments and non-governmental organizations in areas such strengthening clinical and laboratory systems and practices, reducing maternal and newborn mortality, advancing childhood vaccination safety, eliminating vaccine-preventable diseases and improving safety for health workers and patients. A key area of focus for Mr. Cohen is leading collaborative cross-sector efforts to address the global threat resulting from resistance to antimicrobial medications. Associated with this, in 2017 he founded the Antimicrobial Resistance Fighters Coalition (), presently comprised of diverse stakeholders from 44 countries including government and health agency officials, clinicians, NGO leaders, patients and family members of patients who died from resistant infections.
Mr. Cohen frequently serves as an expert speaker on mobilizing business sector skills and resources to achieve positive societal impact, in various venues such as the United Nations, the Vatican, U.S. Department of State, World Bank, World Health Assembly and World Economic Forum-Davos. He has been honored by numerous organizations for his humanitarian work. Mr. Cohen holds a B.A. and an M.B.A. from Rutgers University and previously served on the university’s board of trustees. In 2016 he was named a Rutgers 250 Fellow in association with the university’s 250th anniversary. In 2018, Rutgers Business School announced its collaboration with Mr. Cohen as the founder of the new Rutgers Institute for Corporate Social Innovation ().